Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-068864

Chief Executive Officer bought 10,000 shares at $2.27 ($22,700)

From the SEC's structured data for this filing

Trades in this filing

Imran Talat · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-06 Purchase : show line 1 in the form +10,000 $2.27 $22,700 484,455 D
Open-market purchases · 10,000 sh · avg $2.27 · $22,700
Loading xslF345X05/ownership.xml…